Nancy Denyes Biography and Net Worth

General Counsel of aTyr Pharma

Nancy Denyes is the General Counsel of aTyr Pharma. They are 58 years old.

What is Nancy Denyes' net worth?: The estimated net worth of Nancy Denyes is at least $5.18 thousand as of February 4th, 2026. Denyes owns 828 shares of aTyr Pharma stock worth more than $5,179 as of November 3rd. This net worth evaluation does not reflect any other assets that Denyes may own. Learn More about Nancy Denyes' net worth.
How do I contact Nancy Denyes?: The corporate mailing address for Denyes and other aTyr Pharma executives is 10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 92121. aTyr Pharma can also be reached via phone at (858) 731-8389 and via email at [email protected]. Learn More on Nancy Denyes' contact information.
Has Nancy Denyes been buying or selling shares of aTyr Pharma?: Nancy Denyes has not been actively trading shares of aTyr Pharma during the last quarter. Most recently, Nancy Denyes sold 27 shares of the business's stock in a transaction on Wednesday, February 4th. The shares were sold at an average price of $39.20, for a transaction totalling $1,058.40. Following the completion of the sale, the general counsel now directly owns 828 shares of the company's stock, valued at $32,457.60. Learn More on Nancy Denyes' trading history.
Who are aTyr Pharma's active insiders?: aTyr Pharma's insider roster includes Jill Broadfoot (CFO), Nancy Denyes (General Counsel), Jane Gross (Director), Paul Schimmel (Director), and Sanjay Shukla (President and CEO, Director). Learn More on aTyr Pharma's active insiders.
Are insiders buying or selling shares of aTyr Pharma?: In the last year, aTyr Pharma insiders bought shares 1 times. They purchased a total of 2,500 shares worth more than $50,000.00. In the last year, insiders at the sold shares 3 times. They sold a total of 158 shares worth more than $6,193.60. The most recent insider tranaction occured on May, 27th when Director Paul Schimmel bought 2,500 shares worth more than $50,000.00. Insiders at aTyr Pharma own 5.0% of the company. Learn More about insider trades at aTyr Pharma.
Information on this page was last updated on 5/27/2026.

Nancy Denyes Insider Trading History at aTyr Pharma

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
2/4/2026	Sell	27	$39.20	$1,058.40	828
2/4/2025	Sell	22	$151.20	$3,326.40	663

Nancy Denyes Buying and Selling Activity at aTyr Pharma

aTyr Pharma Company Overview

aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1. The company was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.

Today's Range

Now: $6.26

$6.24

$7.22

50 Day Range

MA: $12.94

$4.94

$22.80

2 Week Range

Now: $6.26

$4.07

$44.40

Volume

178,830 shs

Average Volume

65,479 shs

Market Capitalization

$15.34 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.91